Relapsing COVID-19 infection as a manifestation of Good syndrome: a case report and literature review

Int J Infect Dis. 2023 Apr:129:236-239. doi: 10.1016/j.ijid.2022.12.040. Epub 2023 Jan 3.

Abstract

Good syndrome (GS) is a rare acquired immunodeficiency disease characterized by the presence of thymoma with combined B and T cell immunodeficiency in adults. Recurrent bacterial infections, particularly sinopulmonary infections caused by encapsulated bacteria, remain the most common infective presentation of GS; however, relapsing viral infections have also been reported, likely due to impaired T cell-mediated immunity. Relapsing COVID-19 infection, however, has not been previously reported as a manifestation of GS. We present two cases of relapsing COVID-19 infection in patients with GS; in one case, relapsing COVID-19 was the first manifestation of newly diagnosed GS.

Keywords: COVID-19; Good syndrome; Immunocompromise; Relapse; SARS-CoV-2.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Adult
  • COVID-19*
  • Humans
  • Immunologic Deficiency Syndromes* / complications
  • Immunologic Deficiency Syndromes* / diagnosis
  • Neoplasm Recurrence, Local
  • Primary Immunodeficiency Diseases*
  • Thymoma* / complications
  • Thymoma* / diagnosis
  • Thymus Neoplasms* / diagnosis